Hollow fiber bioreactor: new development for the study of contrast agent transport into hepatocytes by magnetic resonance imaging

Autor: Corinne, Planchamp, Marko K, Ivancevic, Catherine M, Pastor, Jean-Paul, Vallée, Sibylle, Pochon, François, Terrier, Joachim M, Mayer, Marianne, Reist

Publikováno v: Biotechnology and bioengineering
Biotechnology and Bioengineering, Vol. 85, No 6 (2004) pp. 656-65

The aim of our study was to develop a magnetic resonance (MR)-compatible in vitro model containing freshly isolated rat hepatocytes to study the transport of hepatobiliary contrast agents (CA) by MR imaging (MRI). We set up a perfusion system includi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9e7edc4ba1e70792f9527698d3aff4f8

Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study

Autor: Sergey V, Nesterov, Emmanuel, Deshayes, Roberto, Sciagrà, Leonardo, Settimo, Jerome M, Declerck, Xiao-Bo, Pan, Keiichiro, Yoshinaga, Chietsugu, Katoh, Piotr J, Slomka, Guido, Germano, Chunlei, Han, Ville, Aalto, Adam M, Alessio, Edward P, Ficaro, Benjamin C, Lee, Stephan G, Nekolla, Kilem L, Gwet, Robert A, deKemp, Ran, Klein, John, Dickson, James A, Case, Timothy, Bateman, John O, Prior, Juhani M, Knuuti

Publikováno v: JACC: Cardiovascular Imaging
JACC: Cardiovascular Imaging, 2014, 7, pp.1119--27. ⟨10.1016/j.jcmg.2014.08.003⟩
JACC: Cardiovascular Imaging, Elsevier/American College of Cardiology, 2014, 7, pp.1119--27. ⟨10.1016/j.jcmg.2014.08.003⟩

International audience; OBJECTIVES: The purpose of this study was to compare myocardial blood flow (MBF) and myocardial flow reserve (MFR) estimates from rubidium-82 positron emission tomography ((82)Rb PET) data using 10 software packages (SPs) base

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::59e1be996bd9a9854b7a483fd035f597
https://hal.umontpellier.fr/hal-02181341

Synthesis of Tc-99m-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes

Autor: Christophe Van de Wiele, Alberto Signore, Graziana Palmieri, Calogero D'Alessandria, Bart Cornelissen, Francesco Scopinaro, Rudi Dierckx, Maurizio Mattei, Elena Bonanno, Alessio Annovazzi, Stephen J. Mather

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging, 33(4), 474-482. SPRINGER

Purpose: Few radiopharmaceuticals have been described for the study of lymphocyte trafficking despite its high clinical relevance. The main difficulty resides in the identification of a suitable highly specific probe to target these cells. Interleuki

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::268288bd4e9b63dae0faf3131a8172ce
http://www.scopus.com/inward/record.url?eid=2-s2.0-33645889985&partnerID=MN8TOARS

A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations

Autor: Sophie Tezenas du Montcel, Alexis Brice, Yves Agid, Stéphane Thobois, Maria-Joao Ribeiro, Emmanuel Broussolle, Luc Mallet, Bruno Dubois, Pierre Pollak, Philippe Remy, Ebba Lohmann, Suzanne Lesage, Antoine Pelissolo

Publikováno v: Journal of Nuclear Medicine
Journal of Nuclear Medicine, 2009, 50 (8), pp.1244-50. ⟨10.2967/jnumed.109.063529⟩
Journal of Nuclear Medicine, Vol. 50, No 8 (2009) pp. 1244-1250
Journal of Nuclear Medicine, Society of Nuclear Medicine, 2009, 50 (8), pp.1244-50. ⟨10.2967/jnumed.109.063529⟩

International audience; The impact of parkin gene mutations on nigrostriatal dopaminergic degeneration is not well established. The purpose of this study was to characterize by PET using (18)F-fluoro-l-3,4-dihydroxyphenylalanine ((18)F-fluoro-l-DOPA)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad9e6aad8cf535590623170fda48f857
https://www.hal.inserm.fr/inserm-00529647

Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors

Autor: Claudia Bodenstein, Michael E. Phelps, Kevin J. Kim, Yann Seimbille, Wolfgang A. Weber, Johannes Czernin, Helen Su, Steven M. Dubinett, Barbara J. Fueger, Gregory Z. Ferl, Yu-Tien Hsu

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, No 6 (2008) pp. 1089-1099

PURPOSE: Gefitinib, an inhibitor of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK), has shown potent effects in a subset of patients carrying specific EGFR-TK mutations in advanced non-small-cell lung cancer. In this study, we asked w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::383edb0e75e71b0c1d1aa8e2fe9eb305
https://archive-ouverte.unige.ch/unige:19093